Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment
Schnabel A., Reuter M., Biederer J., et al. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum 32 (2003) 273-284
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
Ginzler E.M., Dooley M.A., Aranow C., et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 353 (2005) 2219-2228
Induction of remission in active antineutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide
Stassen P.M., Cohen Tervaert J.W., and Stegeman C.A. Induction of remission in active antineutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide. Ann Rheum Dis 66 (2007) 798-802
Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy
Majithia V., and Harisdangkul V. Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy. Rheumatology (Oxford) 44 (2005) 386-389
In vitro evidence for a direct antifibrotic role of the immunosuppressive drug mycophenolate mofetil
Roos N., Poulalhon N., Farge D., et al. In vitro evidence for a direct antifibrotic role of the immunosuppressive drug mycophenolate mofetil. J Pharmacol Exp Ther 321 (2007) 583-589
Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease
Gerbino A.J., Goss C.H., and Molitor J.A. Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease. Chest 133 (2008) 455-460
Rheumatoid arthritis interstitial lung disease: mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug
Saketkoo L.A., and Espinoza L.R. Rheumatoid arthritis interstitial lung disease: mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug. Arch Intern Med 168 (2008) 1718-1719
Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis
Chan T.M., Tse K.C., Tang C.S., et al. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. J Am Soc Nephrol 16 (2005) 1076-1084